Android app on Google Play

Raymond James Downgrades Genomic Health (GHDX) to Underperform

September 23, 2013 7:24 AM EDT Send to a Friend
Get Alerts GHDX Hot Sheet
Price: $26.65 -3.06%

Rating Summary:
    6 Buy, 6 Hold, 5 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 23 | Down: 25 | New: 18
Trade GHDX Now!
Join SI Premium – FREE
Raymond James downgraded Genomic Health Inc. (NASDAQ: GHDX) from Market Perform to Underperform.

For an analyst ratings summary and ratings history on Genomic Health Inc. click here. For more ratings news on Genomic Health Inc. click here.

Shares of Genomic Health Inc. closed at $32.46 yesterday.




You May Also Be Interested In


Related Categories

Downgrades

Related Entities

Raymond James

Add Your Comment